)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Poltreg
Poltreg (PTG) investor relations material
Poltreg Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary19 Nov, 2025
Executive summary
Focused on developing innovative Treg cell therapies for autoimmune diseases, with leading clinical programs in type 1 diabetes and multiple sclerosis.
Maintains a strong R&D pipeline, including next-generation Treg therapies and mRNA-based approaches.
Received significant grants and expanded international collaborations, including a new US subsidiary.
Financial highlights
Revenue for the nine months ended 30 September 2025 was 350k PLN, flat year-over-year.
Net loss for the period was 20,033k PLN, compared to 14,179k PLN in the prior year.
Operating expenses increased to 26,454k PLN, driven by higher R&D, amortization, and utility costs.
Cash and equivalents at period end totaled 24,690k PLN, down from 45,655k PLN at year-end 2024.
Equity decreased to 49,480k PLN from 69,234k PLN at year-end 2024.
Outlook and guidance
Strategic focus on partnering with major pharma for commercialization and further clinical development.
Sufficient cash for planned activities, but future clinical progress depends on continued grant funding.
Key upcoming milestones include patient recruitment in phase II trials and IND submission in the US.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Poltreg
- Net loss nearly doubled as revenue fell, but key clinical and grant milestones were achieved.PTG
Q2 202411 Mar 2026 - Revenue dropped sharply as clinical and regulatory progress accelerated, with losses offset by strong cash and grants.PTGQ4 202411 Mar 2026
- Losses increased as revenue fell, but clinical and patent milestones position the pipeline for future growth.PTGQ3 202411 Mar 2026
- Q1 2025 marked higher losses, no sales, and key advances in TREG therapy R&D and partnerships.PTGQ1 202511 Mar 2026
- Net loss deepened, cash reserves fell, but major clinical and regulatory milestones were achieved.PTGQ2 202511 Mar 2026
Next Poltreg earnings date
Q4 202530 Apr, 2026
Poltreg
Next Poltreg earnings date
Q4 202530 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage